Organovo Stock Up 1.5 %
NASDAQ:ONVO opened at $1.39 on Thursday. Organovo has a 52 week low of $1.00 and a 52 week high of $3.40. The firm has a 50 day moving average of $1.30 and a 200 day moving average of $1.52. The stock has a market capitalization of $12.12 million, a price-to-earnings ratio of -0.65 and a beta of 0.84.
Insider Activity at Organovo
In related news, Director David Gobel sold 19,607 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $1.62, for a total transaction of $31,763.34. Following the completion of the sale, the director now owns 19,607 shares of the company’s stock, valued at $31,763.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.00% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Organovo
Organovo Company Profile
Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
- Five stocks we like better than Organovo
- Investing In Preferred Stock vs. Common Stock
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 11/13 – 11/17
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.